Stocks
Grifols, S.A.GRFS
NASDAQHealthcareBiotechnology$7.81-2.01%
A global healthcare company specializing in plasma-derived medicines, operating one of the largest plasma collection networks worldwide. Investors monitor Grifols for its position in the plasma protein therapeutics market and its vertically integrated business model spanning donation centers to finished products.
Market Cap: $6.6B52W Range: $6.19 – $11.14
Congressional Interest in Grifols, S.A. (GRFS)
3 members of Congress have disclosed 4 trades in Grifols, S.A. (GRFS), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 3 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
4
Unique Politicians
3
Buys
1
Sells
3
Who in Congress Is Trading GRFS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-03-31 | Daniel Goldman | sell | $1K – $15K |
| 2023-02-27 | Daniel Goldman | buy | $1K – $15K |